TP53 and breast carcinoma: However, the effect of p53 loss appeared to be modest, which potentially explains why DNA damage foci are not dramatically different between p53‐proficient and p53‐null breast cancer lines, in comparison to RPE1 cells (compare Figs 3D and E with 6C and D).